Additionally, XPO1 has been reported to regulate neurodegeneration in models of frontotemporal dementia and amyotrophic lateral sclerosis (Archbold et al., 2018; Ederle et al., 2018; Steyaert et al., 2018). This evidence concerns the gene XPO1 and frontotemporal dementia.